Bioxtech has newly appeared among the top searched stocks.


As of 2:30 PM on the 10th, Bioxtech is trading at 13,000 KRW, down 0.38% from the previous day. This represents a 29.35% increase compared to August 18. Bioxtech is known as a leading domestic CRO company specializing in non-clinical trials.

Today, foreigners have sold a net 37,000 shares of Bioxtech, while institutions have bought a net 9,000 shares, according to provisional data. Over the past five days, individual investors have bought a net 21,205 shares, whereas foreigners and institutions have sold a net 20,717 shares and 2 shares, respectively.


On September 9, Bioxtech became a market issue with the headline "Rising together with Celltrion's positive news... rising alongside Celltrion..."





[Table] Net Trading Volume of Foreigners and Institutions (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing